4-(N-甲酰基-N-甲基氨基)苯甲酸 | 51865-84-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(N-甲酰基-N-甲基氨基)苯甲酸
• 中文别名: 4-(N-甲酰基-N-甲基)苯甲酸；N-甲酰基-4-(甲基氨基)苯甲酸
• 英文名称: 4-(formyl-methyl-amino)-benzoic acid
• 英文别名: 4-(Formyl-methyl-amino)-benzoesaeure；p-(N-methyl-N-formyl)-aminobenzoic acid；N-formyl-4-(methylamino)benzoic acid；4-(N-Methylformamido)benzoic acid；4-[formyl(methyl)amino]benzoic acid
• CAS: 51865-84-0
• 化学式: C₉H₉NO₃
• 分子量: 179.175
• InChiKey: WEMYEQBKRODOGB-UHFFFAOYSA-N

物化性质

• 熔点：
  217-221 °C
• 沸点：
  311.69°C (rough estimate)
• 密度：
  1.2822 (rough estimate)
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 海关编码：
  2924299090
• 安全说明：
  S26,S37/39

SDS

Name:	N-Formyl-4-(Methylamino)Benzoic Acid Material Safety Data Sheet
Synonym:	None
CAS:	51865-84-0

Section 1 - Chemical Product MSDS Name:N-Formyl-4-(Methylamino)Benzoic Acid Material Safety Data Sheet
Synonym:None

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
51865-84-0	N-Formyl-4-(Methylamino)Benzoic Acid	100	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
Causes skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
The toxicological properties of this substance have not been fully investigated. Causes gastrointestinal tract irritation.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Keep container closed when not in use. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 51865-84-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H9NO3
Molecular Weight: 179.0679

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 51865-84-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-Formyl-4-(Methylamino)Benzoic Acid - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 51865-84-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 51865-84-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 51865-84-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质：该物质为结晶固体，熔点为218℃。

用途：它是甲氨蝶呤的重要中间体。

生产方法：通过将对氨基苯甲酸进行N-甲基化和甲酰化反应而制得。

反应信息

• 作为反应物：
  描述：

  4-(N-甲酰基-N-甲基氨基)苯甲酸 生成 4-[Formyl(methyl)amino]benzoyl chloride
  参考文献：
  名称：

  CATALUCCI, E.

  摘要：

  DOI：
• 作为产物：
  描述：

  4-甲氨基苯甲酸 以 甲酸 、 水 为溶剂， 以97%的产率得到4-(N-甲酰基-N-甲基氨基)苯甲酸
  参考文献：
  名称：

  Process for the production of p-(N-methyl)-aminobenzoyl-L-glutamic acid

  摘要：

  生产对-(N-甲基)-氨基苯甲酰-L-谷氨酸的过程。该过程包括将甲酰基引入对-(N-甲基)-氨基苯甲酸中，形成对-(N-甲基-N-甲酰基)-氨基苯甲酸。将对-(N-甲基-N-甲酰基)-氨基苯甲酸与氯化剂（如磺酰氯或硫酰氯）氯化，形成对-(N-甲基-N-甲酰基)-氨基苯甲酸氯化物。在碱作为酸受体的存在下，将对-(N-甲基-N-甲酰基)-氨基苯甲酸氯化物与L-谷氨酸反应，形成对-(N-甲基-N-甲酰基)-氨基苯甲酰-L-谷氨酸。将对-(N-甲基-N-甲酰基)-氨基苯甲酰-L-谷氨酸在30至70摄氏度的2.5至3.5摩尔氢氧化钠溶液中通过碱性水解转化为对-(N-甲基)-氨基苯甲酰-L-谷氨酸。获得的中间体包括：对-(N-甲基-N-甲酰基)-氨基苯甲酸；对-(N-甲基-N-甲酰基)-氨基苯甲酸氯化物；和对-(N-甲基-N-甲酰基)-氨基苯甲酰-L-谷氨酸。

  公开号：

  US04211883A1

文献信息

• [EN] SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF<br/>[FR] CARBOXAMIDES DE N-PHÉNYL-BIPYRROLIDINE SUBSTITUÉS ET LEUR UTILISATION THÉRAPEUTIQUE
  申请人：SANOFI AVENTIS

  公开号：WO2009052065A1

  公开（公告）日：2009-04-23

  The present invention discloses and claims a series of substituted N-phenyl-bipyrrolidine carboxamides of formula (I), Wherein R, R1, R2, R3 and R4 are as described herein. More specifically, the compounds of this invention are modulators of H3 receptors and are, therefore, useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases modulated by H3 receptors including diseases associated with the central nervous system. Additionally, this invention also discloses methods of preparation of substituted N-phenyl-bipyrrolidine carboxamides and intermediates therefor.

  本发明公开并声明了一系列式(I)的取代N-苯基-双吡咯烷羧酰胺，其中R、R1、R2、R3和R4如本文所述。更具体地说，本发明的化合物是H3受体调节剂，因此在制药方面特别有用，尤其是在治疗和/或预防通过H3受体调节的各种疾病，包括与中枢神经系统相关的疾病。此外，本发明还公开了取代N-苯基-双吡咯烷羧酰胺及其中间体的制备方法。
• Beta-amyloid protein production. secretion inhibitor
  申请人：Yasukouchi Takanori

  公开号：US20050234109A1

  公开（公告）日：2005-10-20

  Provided are novel compounds having an inhibitory activity against production or secretion of β-amyloid protein. They embrace compounds represented by the following formula (1): and capable of being replaced with a variety of substituents; and salts thereof, and solvates of any one of them.

  提供了一种新型化合物，具有抑制β-淀粉样蛋白产生或分泌的活性。它们包括由以下公式（1）表示的化合物：并且能够被各种取代基所替换；以及它们的盐和任何一个溶剂化物。
• Morpholine derivatives
  申请人：Kubota Hideki

  公开号：US20060241302A1

  公开（公告）日：2006-10-26

  Provided is a compound capable of inhibiting production or secretion of β amyloid protein. A compound represented by the following formula (1): (wherein, R 1 represents a heterocyclic group which may have a substituent, R 2 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R 3 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R 4 represents a hydrogen atom or a C 1-6 alkyl group, and X represents —S—, —SO— or —SO 2 —); an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.

  提供了一种能够抑制β淀粉样蛋白产生或分泌的化合物。该化合物由以下公式（1）表示：（其中，R1代表可能具有取代基的杂环基团，R2代表可能具有取代基或杂环基团的环烃基团，R3代表可能具有取代基或杂环基团的环烃基团，R4代表氢原子或C1-6烷基基团，X代表—S—、—SO—或—SO2—）；其N-氧化物或S-氧化物；其盐；或其溶剂化物；以及含有任何一种的药物。
• BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
  申请人：YASUKOUCHI Takanori

  公开号：US20070293495A1

  公开（公告）日：2007-12-20

  Provided are novel compounds having an inhibitory activity against production or secretion of β-amyloid protein. They embrace compounds represented by the following formula (1): and capable of being replaced with a variety of substituents; and salts thereof, and solvates of any one of them.

  提供了一些新化合物，具有抑制β-淀粉样蛋白的产生或分泌活性。它们包括以下式子（1）所代表的化合物：并且可以被各种取代基所替换；以及它们的盐和任何一个的溶剂化物。
• SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF
  申请人：CZECHTIZKY Werngard

  公开号：US20100173897A1

  公开（公告）日：2010-07-08

  The present invention discloses and claims a series of substituted N-phenyl-bipyrrolidine carboxamides of formula (I). Wherein R, R 1 , R 2 , R 3 and R 4 are as described herein. More specifically, the compounds of this invention are modulators of H3 receptors and are, therefore, useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases modulated by H3 receptors including diseases associated with the central nervous system. Additionally, this invention also discloses methods of preparation of substituted N-phenyl-bipyrrolidine carboxamides and intermediates therefor.

  本发明揭示和声明了一系列取代的N-苯基双吡咯烷羧酰胺化合物，其化学式为(I)，其中R、R1、R2、R3和R4如本文所述。更具体地，本发明的化合物是H3受体调节剂，因此在治疗和/或预防包括与中枢神经系统相关的多种H3受体调节的疾病方面，特别是作为药物剂量是有用的。此外，本发明还揭示了取代的N-苯基双吡咯烷羧酰胺及其中间体的制备方法。